metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Unusual microscopic finding in a hepatic abscess content
Información de la revista
Vol. 41. Núm. 4.
Páginas 254-255 (abril 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 41. Núm. 4.
Páginas 254-255 (abril 2023)
Scientific letter
Acceso a texto completo
Unusual microscopic finding in a hepatic abscess content
Hallazgo microscópico inusual en muestra de absceso hepático
Visitas
648
Marta Roloa, Alhena Reyesa, Juan Martín Torresb, Ana Pérez-Ayalaa,c,
Autor para correspondencia
apayalabalzola@salud.madrid.org

Corresponding author.
a Microbiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
b Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain
c Instituto de Investigación Hospital Universitario 12 de Octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Texto completo

Among all parasitic diseases, amoebiasis is the third most frequent cause of mortality in the developing world, with more than 100,000 deaths reported annually.1 In developed countries, mostly immigrants, travelers from endemic areas and men who have sex with men (MSM) are affected.1,2

Entamoeba histolytica is the only invasive among Entamoeba group and has two parasitic forms: cyst and trophozoite stages. Transmission occurs after ingestion of cysts from contaminated food or water or after person-to-person contact (oral-anal sex).1–3 Once cysts reach the small intestine, they become trophozoites, the invasive form.1,4

Extraintestinal disease (10%) is represented by the amoebic liver abscess (ALA). A delay in the correct diagnosis may evolve into rupture of the abscess, with high mortality associated.5 Diagnosis of ALA is mainly serologic, with more than 90% of cases testing positive. Image techniques and direct microscopic visualization, help to make the definitive diagnosis.1,2,6 Visualization of cysts in the abscesses content may occur but is an extraordinary unlikely finding, as the invasive form that reaches the liver is the trophozoite.1,2,7

We here report a case of a 31-year-old transgender woman who was admitted to the ICU presenting with abdominal sepsis secondary to a liver abscess. She referred a frequent habit of alcohol consumption and to be a sex worker, as well as no travels to tropical areas since she arrived in Spain in 2016 from Colombia, her country of origin.

Scan findings showed a 14cm diameter cyst occupying a great part of the right liver lobe. Hematological and biochemical profiles were: Hb 10.0g/dL, Ht 29.2%, CRP 32.77mg/dL, leukocytosis (25,000/μL), GOT 210U/L, GPT 182U/L.

The following day, an echo-guided drainage was performed, obtaining 450cc. Samples were sent to the Microbiology department including serum samples. Empirical antimicrobial therapy was initiated with ceftriaxone 2g/12h and metronidazole 750mg/8h.

Direct observation of the abscess content showed cysts of E. histolytica/dispar (Fig. 1), followed by confirmation of the species by immunochromatography (TECHLAB® E. HISTOLYTICA QUIK CHEK™). Antimicrobial therapy was then readjusted to metronidazole at same dosage plus paromomycin for 10 days.

Fig. 1.

Cyst of Entamoeba histolytica.

(0.06MB).

We have available two different serological tests for the detection of E. histolytica IgG antibodies: one Latex-agglutination technique (BICHRO-LATEX AMIBE FUMOUZE®) and an ELISA assay (SCIMEDX®). The ELISA usually follows a positive agglutination test. In our patient, the latex-agglutination test was positive, but the ELISA assay tested negative. Therefore, a second serum sample was sent 7 days later which tested positive for both tests, indicating seroconversion. Stool samples resulted negative for microscopy examination. Screening for HIV and Hepatitis virus was performed on serum samples, resulting negative for both tests.

At day 5 the patient was discharged from the ICU. Paromomycin was administered for 5 more days once metronidazole was finished. At day 21, discharge from hospital was decided.

Discussion

E. histolytica is a protozoan worldwide distributed.2 In developed countries, institutionalized patients and MSM have a higher risk to become infected.1,2,4 Our patient was a transgender woman who practiced prostitution as a profession. This could be one explanation for the acquisition route. Her consumption of alcohol through a long period of time could also have influenced the ALA formation.5

In non-endemic areas, it is estimated that approximately 50% of patients with symptomatic ALA are misdiagnosed.8 Since patients present with very unspecific symptoms, a good screening diagnosis is determinant for a correct and prompt treatment approach.

Analysis of stool samples is not reliable in extraintestinal disease, as only 15–33% of them are positive.2,8 Instead, serology shows up as a reliable marker in the extraintestinal disease, as sensitivity and specificity of ELISA has been reported to range between 80 and 100%.1–3,5 In the case of our patient, as the serum sample at day 1 was negative the possibility of a false negative result in the first ELISA determination was also considered, therefore, once we had a second sample 7 days later, parallel ELISA determinations were performed, confirming the first negative result and the seroconversion during hospital stay. According to this, it is unknown whether primoinfection occurred in our environment not long ago or in contrast primoinfection occurred years ago in Colombia and the patient stayed colonized until extraintestinal invasion of the parasite occurred. Although in Spain most cases are imported, community acquisition of amoebiasis has also been reported.9

Microscopic examination of the abscess content is a very low sensitive technique. The trophozoites are located in the wall of the abscess, therefore they can only be seen when this area is aspirated, although this happens in less than 20% of samples.7,8,10 In our case, when the fluid arrived in our department, its aspect recalled the typical “anchovy paste” appearance. What is outstanding in this case is that no trophozoites, but cysts were observed under the microscope.

References
[1]
M. Tanyuksel, W.A. Petri Jr..
Laboratory diagnosis of amebiasis.
Clin Microbiol Rev, 16 (2003), pp. 713-729
[2]
R. Fotedar, D. Stark, N. Beebe, D. Marriott, J. Ellis, J. Harkness.
Laboratory diagnostic techniques for Entamoeba species.
Clin Microbiol Rev, 20 (2007), pp. 511-532
[3]
N. Beyls, O. Cognet, J.P. Stahl, O. Rogeaux, H. Pelloux.
Serodiagnosis of extraintestinal amebiasis using Bordier® ELISA kit.
Korean J Parasitol, 56 (2018), pp. 71-74
[4]
T. Maryam, S.S. Morgan, A.R. Deshpande, C. Milikowski.
An unusual case of entamoeba histolytica infection in Miami Fl: case report and review of the literature.
Res Rev Infect Dis, 3 (2020), pp. 40-43
[5]
T.S. Papavramidis, K. Sapalidis, D. Pappas, G. Karagianopoulou, A. Trikoupi, C.H. Souleimanis, et al.
Gigantic hepatic amebic abscess presenting as acute abdomen: a case report.
J Med Case Rep, 2 (2008), pp. 325
[6]
R.N. Priyadarshi, L. Sherin, R. Kumar, U. Anand, P. Kumar.
CT of amebic liver abscess: different morphological types with different clinical features.
Abdom Radiol, 46 (2021), pp. 4148-4158
[7]
J.A. Anesi, S. Gluckman.
Amebic liver abscess.
Clin Liver Dis, 6 (2015), pp. 41-43
[8]
S. Rao, S. Solaymani-Mohammadi, W.A. Petri Jr., S.K. Parker.
Hepatic amebiasis: a reminder of the complications.
Curr Opin Pediatr, 21 (2009), pp. 145-149
[9]
M.J. Gutiérrez-Cisneros, P. Martín-Rabadán, L. Menchén, J.M. García Lechuz, I. Fuentes, T. Gárate, et al.
Absceso hepático amebiano autóctono en España: ¿una enfermedad emergente? Descripción de 2 nuevos casos clínicos y de una técnica diagnóstica basada en la reacción en cadena de la polimerasa.
Enferm Infecc Microbiol Clin, 27 (2009), pp. 323-330
[10]
V. Wiwanitkit.
A note on clinical presentations of amebic liver abscess: an overview from 62 Thai patients.
BMC Fam Pract, 3 (2002), pp. 13
Copyright © 2022. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos